businesspress24.com - Biostem U.S., Corporation Announces National Expansion Plan to Be Implemented by Founding CEO
 

Biostem U.S., Corporation Announces National Expansion Plan to Be Implemented by Founding CEO

ID: 1214054

Founding CEO, John Satino Is Back at the Helm of Biostem U.S. and Is Promoting an Aggressive and Strategic National Expansion Plan to Place The Biostem Method(TM) in Twenty New Clinics Across the Country by the End of This Calendar Year

(firmenpresse) - CLEARWATER, FL -- (Marketwired) -- 04/08/13 -- Biostem U.S., Corporation (OTCQB: HAIR) (PINKSHEETS: HAIR) (Biostem, the Company), a fully reporting public company in the stem cell regenerative medicine sciences sector, today reported that it has reinstated its founder, John Satino as CEO, under whose leadership the Company will launch an aggressive campaign of national expansion and growth into even other fields of regenerative medicine.

Biostem Chief Executive Officer John Satino stated, "After several months of strategic planning, we have decided to realign with our original vision of providing exclusive use of The Biostem Method™ to doctors and clinics across the U.S. It is time to bring our focus back home! I am excited about the future growth Biostem and its affiliates will experience in the upcoming months and years and am proud of the impact we will have on improving the quality of life for patients."



Biostem U.S., Corporation is a fully reporting Nevada corporation with offices in Clearwater, Florida. Biostem is a technology licensing company with proprietary technology centered on providing hair re-growth using human stem cells. The company also intends to train and license selected physicians to provide Regenerative Cellular Therapy treatments to assist the body's natural approach to healing tendons, ligaments, joints and muscle injuries by using the patient's own stem cells. Biostem U.S., Corporation is seeking to expand its operations worldwide through licensing of its proprietary technology and acquisition of existing stem cell related facilities. The company's goal is to operate in the international biotech market, focusing on the rapidly growing regenerative medicine field, using ethically sourced adult stem cells to improve the quality and longevity of life for all mankind.

For further information contact Biostem U.S., Corporation at 727-446-5000, send an email to , or view the Biostem website at .






Contact:
Kerry D'Amato
National Marketing Director
727-446-5000


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Mental Illness in the United States: Gary Larcenaire's Advocacy on Patient Care
EyeGate's EGP-437 Matches the Standard-of-Care's Response Rate in Phase III Study in Patients With Anterior Uveitis
Bereitgestellt von Benutzer: Marketwired
Datum: 08.04.2013 - 06:00 Uhr
Sprache: Deutsch
News-ID 1214054
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

CLEARWATER, FL


Phone:

Kategorie:

Alternative


Anmerkungen:


Diese Pressemitteilung wurde bisher 133 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Biostem U.S., Corporation Announces National Expansion Plan to Be Implemented by Founding CEO
"
steht unter der journalistisch-redaktionellen Verantwortung von

Biostem U.S., Corporation (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Biostem U.S., Corporation



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 110


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.